Current and planned multicenter trials for patients with primary or metastatic melanoma

Vernon K. Sondak, Dale Han, Jeremiah Deneve, Ragini Kudchadkar

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Multicenter clinical trials have established new standards of care in the surgical and medical management of malignant melanoma. They have led to the testing of new therapies and improved outcomes for patients with loco-regional and distant disease. Many pressing questions remain, however, and additional multicenter trials are currently underway to address them. The purpose of this review is to summarize relevant ongoing and planned multicenter trials that have and continue to define current melanoma management.

Original languageEnglish (US)
Pages (from-to)430-437
Number of pages8
JournalJournal of Surgical Oncology
Volume104
Issue number4
DOIs
StatePublished - Sep 1 2011
Externally publishedYes

Fingerprint

Multicenter Studies
Melanoma
Standard of Care
Clinical Trials
Therapeutics

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this

Current and planned multicenter trials for patients with primary or metastatic melanoma. / Sondak, Vernon K.; Han, Dale; Deneve, Jeremiah; Kudchadkar, Ragini.

In: Journal of Surgical Oncology, Vol. 104, No. 4, 01.09.2011, p. 430-437.

Research output: Contribution to journalReview article

Sondak, Vernon K. ; Han, Dale ; Deneve, Jeremiah ; Kudchadkar, Ragini. / Current and planned multicenter trials for patients with primary or metastatic melanoma. In: Journal of Surgical Oncology. 2011 ; Vol. 104, No. 4. pp. 430-437.
@article{608f8eac83314f4fb61f9e5b7527ac7e,
title = "Current and planned multicenter trials for patients with primary or metastatic melanoma",
abstract = "Multicenter clinical trials have established new standards of care in the surgical and medical management of malignant melanoma. They have led to the testing of new therapies and improved outcomes for patients with loco-regional and distant disease. Many pressing questions remain, however, and additional multicenter trials are currently underway to address them. The purpose of this review is to summarize relevant ongoing and planned multicenter trials that have and continue to define current melanoma management.",
author = "Sondak, {Vernon K.} and Dale Han and Jeremiah Deneve and Ragini Kudchadkar",
year = "2011",
month = "9",
day = "1",
doi = "10.1002/jso.21867",
language = "English (US)",
volume = "104",
pages = "430--437",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Current and planned multicenter trials for patients with primary or metastatic melanoma

AU - Sondak, Vernon K.

AU - Han, Dale

AU - Deneve, Jeremiah

AU - Kudchadkar, Ragini

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Multicenter clinical trials have established new standards of care in the surgical and medical management of malignant melanoma. They have led to the testing of new therapies and improved outcomes for patients with loco-regional and distant disease. Many pressing questions remain, however, and additional multicenter trials are currently underway to address them. The purpose of this review is to summarize relevant ongoing and planned multicenter trials that have and continue to define current melanoma management.

AB - Multicenter clinical trials have established new standards of care in the surgical and medical management of malignant melanoma. They have led to the testing of new therapies and improved outcomes for patients with loco-regional and distant disease. Many pressing questions remain, however, and additional multicenter trials are currently underway to address them. The purpose of this review is to summarize relevant ongoing and planned multicenter trials that have and continue to define current melanoma management.

UR - http://www.scopus.com/inward/record.url?scp=80052002462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052002462&partnerID=8YFLogxK

U2 - 10.1002/jso.21867

DO - 10.1002/jso.21867

M3 - Review article

VL - 104

SP - 430

EP - 437

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 4

ER -